STC Life Successfully Differentiates an Osteoblast using its Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC -nEPS)

Kooki News

February 4, 2014

Stem Cell Treatment & Research Institute (STRI) and 97.7 B&H Clinic under STC Life announced that they have successfully differentiated an Osteoblast cell using the Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC-nEPS) click here to find out more.

STC’s Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC-nEPS) doesn’t use induced Pluripotent Stem Cells but natural compounds and its differentiation rate is found to be some 40% faster.

“STC-nEPS has the ability to differentiate into every organs and showed superior differentiation ratio as compared to Mesenchymal Stem Cells. Using this outcome in a clinical trial is expected to show superior outcome in treatment efficacy,” commented Dr. Sang-hyun Lee.